These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2565844)

  • 1. Costs of medical and surgical treatment of duodenal ulcer.
    Sonnenberg A
    Gastroenterology; 1989 Jun; 96(6):1445-52. PubMed ID: 2565844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of different strategies for treatment of duodenal ulcer.
    Sonnenberg A
    Br Med J (Clin Res Ed); 1985 Apr; 290(6476):1185-7. PubMed ID: 2859078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Costs of duodenal ulcer therapy with antibiotics.
    Sonnenberg A; Townsend WF
    Arch Intern Med; 1995 May; 155(9):922-8. PubMed ID: 7726700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decision analysis of histamine H2-receptor antagonist maintenance therapy versus Helicobacter pylori eradication therapy: a randomised controlled trial in patients with continuing pain after duodenal ulcer.
    Tavakoli M; Prach AT; Malek M; Hopwood D; Senior BW; Murray FE
    Pharmacoeconomics; 1999 Oct; 16(4):355-65. PubMed ID: 10623364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic and health aspects of peptic ulcer disease and H2-receptor antagonists.
    Jensen DM
    Am J Med; 1986 Oct; 81(4B):42-8. PubMed ID: 2877574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cost analysis of alternative treatments for duodenal ulcer.
    Imperiale TF; Speroff T; Cebul RD; McCullough AJ
    Ann Intern Med; 1995 Nov; 123(9):665-72. PubMed ID: 7574221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Economic effectiveness of conservative and surgical methods of treatment of duodenal ulcer in young patients].
    Kuzin MI; Kuzin NM; Egorov AV
    Khirurgiia (Mosk); 1991 Mar; (3):14-9. PubMed ID: 1907332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinico-economical effectiveness of conservative and surgical treatment of duodenal ulcer (results of 5-year study)].
    Polous IuM; Shidlovskiĭ VA; Kurko VS; Zavadskaia TS; Lykova NV
    Klin Khir (1962); 1989; (8):22-4. PubMed ID: 2509781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decision analysis of Helicobacter pylori eradication therapy using omeprazole with either clarithromycin or amoxicillin.
    Craig AM; Davey P; Malek M; Murray F
    Pharmacoeconomics; 1996 Jul; 10(1):79-92. PubMed ID: 10160472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of treatment regimens for the eradication of Helicobacter pylori in duodenal ulcer.
    Vakil N; Fennerty MB
    Am J Gastroenterol; 1996 Feb; 91(2):239-45. PubMed ID: 8607487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of Helicobacter pylori eradication for the long-term management of duodenal ulcer in Canada.
    O'Brien B; Goeree R; Mohamed AH; Hunt R
    Arch Intern Med; 1995 Oct; 155(18):1958-64. PubMed ID: 7575049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermittent treatment of duodenal ulcer for long term medical management.
    Bardhan KD
    Postgrad Med J; 1988; 64 Suppl 1():40-6. PubMed ID: 2901744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.
    Bardhan KD
    Yale J Biol Med; 1996; 69(3):211-24. PubMed ID: 9165690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The long-term effects of vagotomy and drainage, parietal cell vagotomy and H2 receptor antagonists on duodenal ulcers and gastric function and structure.
    Bank S; Marks IN; Louw JH
    S Afr Med J; 1980 Apr; 57(16):622-7. PubMed ID: 6103589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy of resistant duodenal ulcer].
    Vigneri S; Scialabba A; Pisciotta G; Termini R; Muratore F; Vinti M
    Minerva Med; 1989 Nov; 80(11):1205-10. PubMed ID: 2574838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. H2-receptor antagonists and duodenal ulcer recurrence: analysis of efficacy and commentary on safety, costs, and patient selection.
    Freston JW
    Am J Gastroenterol; 1987 Dec; 82(12):1242-9. PubMed ID: 2891294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term treatment of duodenal ulcer.
    Wormsley KG
    S Afr Med J; 1984 Jun; 65(25):1001-4. PubMed ID: 6328683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost-effectiveness of maintenance therapy for duodenal ulceration with an H2-antagonist.
    Fox N; Morton RE; Jacobs J
    Aliment Pharmacol Ther; 1988 Aug; 2(4):297-309. PubMed ID: 2908756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long term H2 antagonists in peptic ulcer disease.
    Cooper GJ; Kerrigan DD; Johnson AG
    BMJ; 1988 Dec; 297(6663):1612. PubMed ID: 2906261
    [No Abstract]   [Full Text] [Related]  

  • 20. [10 years' results following proximal selective vagotomy in duodenal ulcer disease. A prospective study].
    Teichmann RK; Cappeller WA; Krämling HJ; Pratschke E
    Chirurg; 1985 Aug; 56(8):515-21. PubMed ID: 2864223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.